Global High Content Screening (HCS) Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application

High-content screening (HCS) technology involves imaging-based multi-parametric analysis at the single-cell level. This technology was initially developed to complement biological high throughput screening in drug discovery. HCS analyses phenotypic changes in cellular samples.
Owing to enhanced toxicity studies, demand for novel technologies in cell analysis is increasing rapidly across the globe. Instruments with enhanced cell imaging and analysis are preferred for early as well as later stages of the drug discovery process. This is expected to fuel the demand for High Content Screening (HCS) instruments in the near future. Also, increasing government support for life sciences research and increasing progress towards establishment of innovation and research-based biotechnology industries, primarily in countries such as China and India, is expected to contribute towards increased growth rate during the forecast period.

Market Analysis and Insights: Global High Content Screening (HCS) Market
The research report studies the High Content Screening (HCS) market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global High Content Screening (HCS) market size is projected to reach US$ 993.8 million by 2026, from US$ 614.5 million in 2020, at a CAGR of 8.3% during 2021-2026.

Global High Content Screening (HCS) Scope and Segment
The global High Content Screening (HCS) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global High Content Screening (HCS) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.

Segment by Type, the High Content Screening (HCS) market is segmented into
Cell Imaging & Analysis System
Flow Cytometry
Consumable
Software
Service

Segment by Application, the High Content Screening (HCS) market is segmented into
Primary & Secondary Screening
Toxicity Studies
Target Identification & Validation

Global High Content Screening (HCS) market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.

The major vendors covered:
Becton, Dickinson and Company
GE Healthcare
Danaher
PerkinElmer
Thermo Fisher Scientific

Frequently Asked Questions